Abstract | BACKGROUND: METHODS: RESULTS: After 24-h reperfusion, based on the histopathologic analysis, compared with NS control group, the liver function was improved in breviscapine group. Liver enzymes aspartate and alanine aminotransferase levels were significantly lower in the I/R + Bre group, when compared with the I/R + NS group. Pretreatment with breviscapine reduced MDA level (P < 0.05) and increased SOD activity significantly in I/R + Bre compared with I/R + NS group. Western blot and RT-q polymerase chain reaction showed that Mfn2 was significantly downregulated in breviscapine preconditioning group as compared to normal saline control group. CONCLUSIONS:
|
Authors | Yan-Zhu Lin, Zhi-Yuan Lu, Xiao-Hui Liang, Kang Li, Bo Peng, Jin Gong |
Journal | The Journal of surgical research
(J Surg Res)
Vol. 203
Issue 2
Pg. 268-74
(06 15 2016)
ISSN: 1095-8673 [Electronic] United States |
PMID | 27363631
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers
- Drugs, Chinese Herbal
- Flavonoids
- Protective Agents
- breviscapine
|
Topics |
- Animals
- Biomarkers
(metabolism)
- Blotting, Western
- Drug Administration Schedule
- Drugs, Chinese Herbal
(pharmacology, therapeutic use)
- Flavonoids
(pharmacology, therapeutic use)
- Injections, Intravenous
- Liver
(drug effects, metabolism, pathology)
- Male
- Oxidative Stress
(drug effects)
- Protective Agents
(pharmacology, therapeutic use)
- Random Allocation
- Rats
- Rats, Sprague-Dawley
- Real-Time Polymerase Chain Reaction
- Reperfusion Injury
(metabolism, pathology, prevention & control)
- Treatment Outcome
|